MCLAM: a cost-effective deep learning model for predicting recurrence risk in HR+/HER2- breast cancer-a multi-center study in a Chinese cohort
{{output}}
Objective: EndoPredict is a gold-standard for HR+/HER2- breast cancer risk stratification but limited by high cost. We propose Multi-modal Clustering-constrained Attention Multiple Instance Learning (MCLAM), a novel deep learning... ...
